118 related articles for article (PubMed ID: 25303215)
1. Carboxylated hydroxyethyl starch: a novel polysaccharide for the delivery of doxorubicin.
Paleos CM; Sideratou Z; Theodossiou TA; Tsiourvas D
Chem Biol Drug Des; 2015 May; 85(5):653-8. PubMed ID: 25303215
[TBL] [Abstract][Full Text] [Related]
2. Characterization and compatibility of hydroxyethyl starch-polyethylenimine copolymers for DNA delivery.
Noga M; Edinger D; Wagner E; Winter G; Besheer A
J Biomater Sci Polym Ed; 2014; 25(9):855-71. PubMed ID: 24787557
[TBL] [Abstract][Full Text] [Related]
3. Characterization and anti-tumor activity of chemical conjugation of doxorubicin in polymeric micelles (DOX-P) in vitro.
Zhao YZ; Sun CZ; Lu CT; Dai DD; Lv HF; Wu Y; Wan CW; Chen LJ; Lin M; Li XK
Cancer Lett; 2011 Dec; 311(2):187-94. PubMed ID: 21872982
[TBL] [Abstract][Full Text] [Related]
4. A systematic evaluation of hydroxyethyl starch as a potential nanocarrier for parenteral drug delivery.
Narayanan D; Nair S; Menon D
Int J Biol Macromol; 2015 Mar; 74():575-84. PubMed ID: 25572720
[TBL] [Abstract][Full Text] [Related]
5. Redox-Sensitive Hydroxyethyl Starch-Doxorubicin Conjugate for Tumor Targeted Drug Delivery.
Hu H; Li Y; Zhou Q; Ao Y; Yu C; Wan Y; Xu H; Li Z; Yang X
ACS Appl Mater Interfaces; 2016 Nov; 8(45):30833-30844. PubMed ID: 27791359
[TBL] [Abstract][Full Text] [Related]
6. Assembled microcapsules by doxorubicin and polysaccharide as high effective anticancer drug carriers.
Du C; Zhao J; Fei J; Cui Y; Li J
Adv Healthc Mater; 2013 Sep; 2(9):1246-51. PubMed ID: 23554398
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyethyl starch conjugates for improving the stability, pharmacokinetic behavior and antitumor activity of 10-hydroxy camptothecin.
Li G; Li Y; Tang Y; Zhang Y; Zhang Y; Yin T; Xu H; Cai C; Tang X
Int J Pharm; 2014 Aug; 471(1-2):234-44. PubMed ID: 24861941
[TBL] [Abstract][Full Text] [Related]
8. Block co-polymer nanoparticles with degradable cross-linked core and low-molecular-weight PEG corona for anti-tumour drug delivery.
Abraham G; McCarroll J; Byrne F; Saricilar S; Kavallaris M; Bulmus V
J Biomater Sci Polym Ed; 2011; 22(8):1001-22. PubMed ID: 20566070
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of N-succinyl-N'-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity.
Xiangyang X; Ling L; Jianping Z; Shiyue L; Jie Y; Xiaojin Y; Jinsheng R
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):222-8. PubMed ID: 17254755
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable ZnO@polymer core-shell nanocarriers: pH-triggered release of doxorubicin in vitro.
Zhang ZY; Xu YD; Ma YY; Qiu LL; Wang Y; Kong JL; Xiong HM
Angew Chem Int Ed Engl; 2013 Apr; 52(15):4127-31. PubMed ID: 23463695
[No Abstract] [Full Text] [Related]
11. ProHES: hydroxyethyl starch's transformative role in anticancer drug delivery.
Prasher P; Sharma M
Future Med Chem; 2024; 16(9):811-816. PubMed ID: 38606535
[No Abstract] [Full Text] [Related]
12. Hyaluronic acid-modified multiwalled carbon nanotubes for targeted delivery of doxorubicin into cancer cells.
Cao X; Tao L; Wen S; Hou W; Shi X
Carbohydr Res; 2015 Mar; 405():70-7. PubMed ID: 25500334
[TBL] [Abstract][Full Text] [Related]
13. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
[TBL] [Abstract][Full Text] [Related]
14. Photo-cross-linked and pH-sensitive biodegradable micelles for doxorubicin delivery.
Chen J; Ouyang J; Kong J; Zhong W; Xing MM
ACS Appl Mater Interfaces; 2013 Apr; 5(8):3108-17. PubMed ID: 23530535
[TBL] [Abstract][Full Text] [Related]
15. Proof of concept for inhibiting metastasis: circulating tumor cell-triggered localized release of anticancer agent via a structure-switching aptamer.
Chen N; Yang X; Wang Q; Jian L; Shi H; Qin S; Wang K; Huang J; Liu W
Chem Commun (Camb); 2016 May; 52(41):6789-92. PubMed ID: 27121864
[TBL] [Abstract][Full Text] [Related]
16. Polymeric micelles with citraconic amide as pH-sensitive bond in backbone for anticancer drug delivery.
Cao J; Su T; Zhang L; Liu R; Wang G; He B; Gu Z
Int J Pharm; 2014 Aug; 471(1-2):28-36. PubMed ID: 24836667
[TBL] [Abstract][Full Text] [Related]
17. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
[TBL] [Abstract][Full Text] [Related]
18. Enhanced doxorubicin delivery and cytotoxicity in multidrug resistant cancer cells using multifunctional magnetic nanoparticles.
Pilapong C; Keereeta Y; Munkhetkorn S; Thongtem S; Thongtem T
Colloids Surf B Biointerfaces; 2014 Jan; 113():249-53. PubMed ID: 24103503
[TBL] [Abstract][Full Text] [Related]
19. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier.
Zhou T; Zhou X; Xing D
Biomaterials; 2014 Apr; 35(13):4185-94. PubMed ID: 24513318
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable protein-based rockets for drug transportation and light-triggered release.
Wu Z; Lin X; Zou X; Sun J; He Q
ACS Appl Mater Interfaces; 2015 Jan; 7(1):250-5. PubMed ID: 25496011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
